Literature DB >> 4197983

Pulmonary host defenses. II. Interaction of respiratory antibodies with Pseudomonas aeruginosa and alveolar macrophages.

H Y Reynolds, R E Thompson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4197983

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  31 in total

1.  Mucosal and systemic immune responses in BALB/c mice to Bacteroides gingivalis fimbriae administered orally.

Authors:  T Ogawa; H Shimauchi; S Hamada
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

2.  Factors influencing the immune enhancement of intrapulmonary bactericidal mechanisms.

Authors:  G J Jakab
Journal:  Infect Immun       Date:  1976-08       Impact factor: 3.441

3.  Effect of presensitization of Nocardia asteroides with specific antibody on the viability of the organism.

Authors:  O U Osoagbaka
Journal:  World J Microbiol Biotechnol       Date:  1996-11       Impact factor: 3.312

4.  Functional and ultrastructural changes in alveolar macrophages from rabbits colonized with Bordetella bronchiseptica.

Authors:  B J Zeligs; J D Zeligs; J A Bellanti
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

Review 5.  Review of bovine immunology for the veterinary practitioner.

Authors:  B N Wilkie
Journal:  Can Vet J       Date:  1974-09       Impact factor: 1.008

6.  Proteins of the cystic fibrosis respiratory tract. Fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosis.

Authors:  R B Fick; G P Naegel; S U Squier; R E Wood; J B Gee; H Y Reynolds
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

7.  Contrasting influence of peplomycin and azelastine hydrochloride (Azeptin) on reactive oxygen generation in polymorphonuclear leukocytes, cytokine generation in lymphocytes, and collagen synthesis in fibroblasts.

Authors:  E Ueta; T Osaki; K Yoneda; T Yamamoto
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

8.  Evaluation of type-specific and non-type-specific pseudomonas vaccine for treatment of pseudomonas sepsis during granulocytopenia.

Authors:  L Harvath; B R Andersen
Journal:  Infect Immun       Date:  1976-04       Impact factor: 3.441

9.  Specificity of opsonic antibodies to enhance phagocytosis of Pseudomonas aeruginosa by human alveolar macrophages.

Authors:  H Y Reynolds; J A Kazmierowski; H H Newball
Journal:  J Clin Invest       Date:  1975-08       Impact factor: 14.808

10.  Systemic antibody deficiency in patients without serum immunoglobulin deficiency or with selective IgA deficiency.

Authors:  M A French; G Harrison
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.